| The global problem of antifungal resistance: prevalence, mechanisms, and management DS Perlin, R Rautemaa-Richardson, A Alastruey-Izquierdo The Lancet infectious diseases 17 (12), e383-e392, 2017 | 939 | 2017 |
| Global burden of recurrent vulvovaginal candidiasis: a systematic review DW Denning, M Kneale, JD Sobel, R Rautemaa-Richardson The Lancet infectious diseases 18 (11), e339-e347, 2018 | 543 | 2018 |
| Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I ES Husebye, J Perheentupa, R Rautemaa, O Kämpe Journal of internal medicine 265 (5), 514-529, 2009 | 418 | 2009 |
| Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris L Sherry, G Ramage, R Kean, A Borman, EM Johnson, MD Richardson, ... Emerging infectious diseases 23 (2), 328, 2017 | 397 | 2017 |
| Bacterial aerosols in dental practice–a potential hospital infection problem? R Rautemaa, A Nordberg, K Wuolijoki-Saaristo, JH Meurman Journal of hospital infection 64 (1), 76-81, 2006 | 307 | 2006 |
| The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus MG Fraczek, M Bromley, A Buied, CB Moore, R Rajendran, R Rautemaa, ... Journal of Antimicrobial Chemotherapy 68 (7), 1486-1496, 2013 | 286 | 2013 |
| Oral infections and systemic disease—an emerging problem in medicine R Rautemaa, A Lauhio, MP Cullinan, GJ Seymour Clinical Microbiology and Infection 13 (11), 1041-1047, 2007 | 270 | 2007 |
| Oral candidosis–clinical challenges of a biofilm disease R Rautemaa, G Ramage Critical reviews in microbiology 37 (4), 328-336, 2011 | 254 | 2011 |
| Acetaldehyde production from ethanol by oral streptococci J Kurkivuori, V Salaspuro, P Kaihovaara, K Kari, R Rautemaa, L Grönroos, ... Oral oncology 43 (2), 181-186, 2007 | 224 | 2007 |
| Pulmonary cryptococcosis: a review of pathobiology and clinical aspects F Setianingrum, R Rautemaa-Richardson, DW Denning Medical mycology 57 (2), 133-150, 2019 | 222 | 2019 |
| Immunohistochemical localization of Toll‐like receptors 1–10 in periodontitis A Beklen, M Hukkanen, R Richardson, YT Konttinen Oral microbiology and immunology 23 (5), 425-431, 2008 | 214 | 2008 |
| Candida yeasts in chronic periodontitis tissues and subgingival microbial biofilms in vivo A Järvensivu, J Hietanen, R Rautemaa, T Sorsa, M Richardson Oral diseases 10 (2), 106-112, 2004 | 194 | 2004 |
| Oral and oesophageal squamous cell carcinoma–a complication or component of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED, APS-I) R Rautemaa, J Hietanen, S Niissalo, S Pirinen, J Perheentupa Oral oncology 43 (6), 607-613, 2007 | 187 | 2007 |
| Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of … J Prattes, J Wauters, DR Giacobbe, J Salmanton-García, J Maertens, ... Clinical Microbiology and Infection 28 (4), 580-587, 2022 | 180 | 2022 |
| Complement-resistance mechanisms of bacteria R Rautemaa, S Meri Microbes and Infection 1 (10), 785-794, 1999 | 172 | 1999 |
| Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project M Bassetti, DR Giacobbe, A Vena, C Trucchi, F Ansaldi, M Antonelli, ... Critical Care 23, 1-7, 2019 | 170 | 2019 |
| Transcriptome Assembly and Profiling of Candida auris Reveals Novel Insights into Biofilm-Mediated Resistance R Kean, C Delaney, L Sherry, A Borman, EM Johnson, MD Richardson, ... Msphere 3 (4), 10.1128/msphere. 00334-18, 2018 | 162 | 2018 |
| Predictors of mortality in chronic pulmonary aspergillosis D Lowes, K Al-Shair, PJ Newton, J Morris, C Harris, ... European Respiratory Journal 49 (2), 2017 | 161 | 2017 |
| Analysis of systemic and local odontogenic infection complications requiring hospital care L Seppänen, A Lauhio, C Lindqvist, R Suuronen, R Rautemaa Journal of Infection 57 (2), 116-122, 2008 | 156 | 2008 |
| Effect of pH on In Vitro Susceptibility of Candida glabrata and Candida albicans to 11 Antifungal Agents and Implications for Clinical Use CS Danby, D Boikov, R Rautemaa-Richardson, JD Sobel Antimicrobial agents and chemotherapy 56 (3), 1403-1406, 2012 | 149 | 2012 |
Emilia Peltola née KaivosojaAssociate Professor, University of Turku在 utu.fi 的电子邮件经过验证
Emilia Peltola née KaivosojaAssociate Professor, University of Turku在 utu.fi 的电子邮件经过验证
Jaime Esteban MorenoClinical microbiologist在 fjd.es 的电子邮件经过验证